Shanghai Kehua Bio-Engineering Co.,Ltd

Equities

002022

CNE000001KC9

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
7.31 ^CNY	+3.98%		+7.98%	-35.76%

Apr. 15	Kehua Bio-Engineering Gets Registration Certificates for Two Devices	MT
Apr. 02	Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	CI

Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.

April 01, 2024

From January 1, 2024 to March 31, 2024, the company has repurchased 8,575,800 shares, representing 1.67% for CNY 70.58 million. With this, the company has completed the repurchase of 8,575,800 shares, representing 1.67% for CNY 70.58 million under the buyback announced on October 29, 2023.

Latest news about Shanghai Kehua Bio-Engineering Co.,Ltd

Kehua Bio-Engineering Gets Registration Certificates for Two Devices	Apr. 15	MT
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	Apr. 01	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Board Elections	Mar. 20	CI
Kehua Bio-Engineering Gets Nod to Register Protein Detection Kit	Mar. 05	MT
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) completed the acquisition of 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd.	Feb. 28	CI
Shanghai Kehua Bio-Engineering Gets Approval for Leucine Aminopeptidase Kit	Feb. 18	MT
Xi'an Zhitong Benyi Enterprise Management Partnership Enterprise (Limited Partnership) agreed to acquire 5% stake in Shanghai Kehua Bio-Engineering Co.,Ltd from Zhuhai Baolian Asset Management Co., Ltd. for CNY 514.3 million.	Jan. 11	CI
Tranche Update on Shanghai Kehua Bio-Engineering Co.,Ltd's Equity Buyback Plan announced on October 29, 2023.	Jan. 02	CI
Shanghai Kehua Bio-Engineering Co.,Ltd announces an Equity Buyback for CNY 200 million worth of its shares.	23-10-29	CI
Shanghai Kehua Bio-Engineering Co.,Ltd authorizes a Buyback Plan.	23-10-26	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
Shanghai Kehua Bio-Engineering Co.,Ltd(XSEC:002022) added to S&P Global BMI Index	23-09-18	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-16	CI
Shanghai Kehua Bio-Engineering Registers Hepatitis Detection Kit	23-08-14	MT
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Management Appointments	23-06-29	CI
Kehua Bio-Engineering Registers Diagnostic Reagent	23-06-22	MT
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for the Year 2022, Payable on 10 May 2023	23-04-28	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-21	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Approves Cash Dividend for 2022	23-04-18	CI
Kehua Bio-Engineering Registers Tumor Necrosis Testing Kit	23-04-06	MT
Shanghai Kehua Bio-Engineering Co.,Ltd Proposes Final Cash Dividend for the Year 2022	23-03-23	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
Shanghai Kehua Bio-Engineering Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Kehua Bio-Engineering Obtains Clearance to Sell Magnesium Testing Kit in China	22-10-04	MT

Chart Shanghai Kehua Bio-Engineering Co.,Ltd

Duration

Period

Chart Shanghai Kehua Bio-Engineering Co.,Ltd

More charts

Company Profile

Shanghai Kehua Bio-engineering Co., Ltd. specializes in the development, manufacturing and marketing of diagnostic biological products. The group proposes primarily reagents, in vitro diagnostics agents, automated instruments of detection, etc. China accounts for 91% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
SHANGHAI KEHUA BIO-ENGINEERING CO.,LTD	-35.76%	499M
BIOMÉRIEUX	+1.69%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7.57%	7.61B
DIASORIN S.P.A.	+3.22%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.93%	4.51B
LANTHEUS HOLDINGS, INC.	+8.91%	4.49B
ANDON HEALTH CO., LTD.	+9.21%	2.73B
VITROLIFE AB	-13.87%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.63%	1.73B
MYRIAD GENETICS, INC.	+0.34%	1.64B

Diagnostic & Testing Substances